Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Smith

Showing results (81-90 of 303) with videos related to

Pageof 31
Sort By:
Scientific Reports|October 1, 2020
A fine-scale multi-step approach to understand fish recruitment variabilityPablo Brosset, Andrew Douglas Smith, Stéphane Plourde, et al.
Leukemia & Lymphoma|March 4, 2022
Pembrolizumab for myelodysplastic syndromes after failure of hypomethylating agents in the phase 1b KEYNOTE-013 studyGuillermo Garcia-Manero, Vincent Ribrag, Yayan Zhang, et al.
F1000Research|June 23, 2016
Cannabis microbiome sequencing reveals several mycotoxic fungi native to dispensary grade Cannabis flowersKevin McKernan, Jessica Spangler, Lei Zhang, et al.
Arthritis and Rheumatism|November 28, 2008
Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trialPaul R Fortin, Michal Abrahamowicz, Diane Ferland, et al.
Current Medical Research and Opinion|January 9, 2016
Treatment patterns, overall survival, healthcare resource use and costs in elderly Medicare beneficiaries with chronic myeloid leukemia using second-generation tyrosine kinase inhibitors as second-line therapyB Douglas Smith, Jun Liu, Dominick Latremouille-Viau, et al.
Leukemia & Lymphoma|September 27, 2021
Infections in secondary immunodeficiency patients treated with Privigen<sup>®</sup> or Hizentra<sup>®</sup>: a retrospective US administrative claims study in patients with hematological malignanciesRajiv Mallick, Victoria Divino, B Douglas Smith, et al.
American Journal of Hematology|June 6, 2014
Sorafenib is tolerable and improves clinical outcomes in patients with FLT3-ITD acute myeloid leukemia prior to stem cell transplant and after relapse post-transplantSarah L Sammons, Keith W Pratz, B Douglas Smith, et al.
British Journal of Haematology|April 16, 2003
Anti-tumour activity of interferon-alpha in multiple myeloma: role of interleukin 6 and tumor cell differentiationWilliam Matsui, Carol Ann Huff, Milada Vala, et al.
Blood|July 2, 2002
High-dose cyclophosphamide for refractory autoimmune hemolytic anemiaVictor M Moyo, Douglas Smith, Isadore Brodsky, et al.
Journal of Health Economics and Outcomes Research|May 31, 2021
Long-Acting Injectable Antipsychotic Use in Patients with Schizophrenia and Criminal Justice System EncountersMadhav P Bhatta, Saroj Bista, Antoine C El Khoury, et al.
Pageof 31

Showing results (81-90 of 303) with videos related to

Sort By:
Pageof 31
Scientific Reports|October 1, 2020
A fine-scale multi-step approach to understand fish recruitment variabilityPablo Brosset, Andrew Douglas Smith, Stéphane Plourde, et al.
Leukemia & Lymphoma|March 4, 2022
Pembrolizumab for myelodysplastic syndromes after failure of hypomethylating agents in the phase 1b KEYNOTE-013 studyGuillermo Garcia-Manero, Vincent Ribrag, Yayan Zhang, et al.
F1000Research|June 23, 2016
Cannabis microbiome sequencing reveals several mycotoxic fungi native to dispensary grade Cannabis flowersKevin McKernan, Jessica Spangler, Lei Zhang, et al.
Arthritis and Rheumatism|November 28, 2008
Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trialPaul R Fortin, Michal Abrahamowicz, Diane Ferland, et al.
Current Medical Research and Opinion|January 9, 2016
Treatment patterns, overall survival, healthcare resource use and costs in elderly Medicare beneficiaries with chronic myeloid leukemia using second-generation tyrosine kinase inhibitors as second-line therapyB Douglas Smith, Jun Liu, Dominick Latremouille-Viau, et al.
Leukemia & Lymphoma|September 27, 2021
Infections in secondary immunodeficiency patients treated with Privigen<sup>®</sup> or Hizentra<sup>®</sup>: a retrospective US administrative claims study in patients with hematological malignanciesRajiv Mallick, Victoria Divino, B Douglas Smith, et al.
American Journal of Hematology|June 6, 2014
Sorafenib is tolerable and improves clinical outcomes in patients with FLT3-ITD acute myeloid leukemia prior to stem cell transplant and after relapse post-transplantSarah L Sammons, Keith W Pratz, B Douglas Smith, et al.
British Journal of Haematology|April 16, 2003
Anti-tumour activity of interferon-alpha in multiple myeloma: role of interleukin 6 and tumor cell differentiationWilliam Matsui, Carol Ann Huff, Milada Vala, et al.
Blood|July 2, 2002
High-dose cyclophosphamide for refractory autoimmune hemolytic anemiaVictor M Moyo, Douglas Smith, Isadore Brodsky, et al.
Journal of Health Economics and Outcomes Research|May 31, 2021
Long-Acting Injectable Antipsychotic Use in Patients with Schizophrenia and Criminal Justice System EncountersMadhav P Bhatta, Saroj Bista, Antoine C El Khoury, et al.
Pageof 31